# Geom Therapeutics, Inc. — Form D

Geom Therapeutics, Inc. of SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2017-04-11. The offering totals $4.5M, of which $4.4M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2017-04-11
- Form: D
- Accession: 0001243233-17-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $4.5M
- Amount sold: $4.4M
- Remaining: $145K
- Investors: 17
- Date of first sale: 2017-03-09
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-284519

## Issuer

- Name: Geom Therapeutics, Inc.
- CIK: 0001702693
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2015
- Address: 826A Vallejo Street, SAN FRANCISCO, CA, 94133
- Phone: 415-533-3236

## Officers, directors & promoters (6)

| Name | Role | Location |
| --- | --- | --- |
| COOPER COLLINS | Director | SAN ANTONIO, TX |
| Dov Goldstein | Director | Houston, TX |
| Yong-Zu Kim | Director | San Francisco, CA |
| Sejin Park | Director | San Francisco, CA |
| Dirk Thye | Director | South San Francisco, CA |
| Dirk Thye | Executive Officer | South San Francisco, CA |

## More

- [CIK 1702693 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1702693&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001243233-17-000002.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.